Timothy G Wallace
CIK 1210485 · View on SEC EDGAR ↗
Insider
First SEC filing: Dec. 11, 2017 · Latest: Dec. 11, 2017
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 11 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
11 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 13, 2017 | CHCT | P 10b5-1 | 4,949 | $27.60 | $136,592 | 463,222 Direct | +1.08% | Acquired | -46.9% (price as of 2026-08-20) |
| Dec. 12, 2017 | CHCT | P 10b5-1 | 10,067 | $27.18 | $273,621 | 458,273 Direct | +2.25% | Acquired | -46.1% (price as of 2026-08-20) |
| Dec. 11, 2017 | CHCT | P 10b5-1 | 10,099 | $26.93 | $271,966 | 448,206 Direct | +2.31% | Acquired | -45.6% (price as of 2026-08-20) |
| Dec. 8, 2017 | CHCT | P 10b5-1 | 10,047 | $27.33 | $274,585 | 438,107 Direct | +2.35% | Acquired | -46.4% (price as of 2026-08-20) |
| Dec. 7, 2017 | CHCT | P 10b5-1 | 10,016 | $26.85 | $268,930 | 428,060 Direct | +2.40% | Acquired | -45.4% (price as of 2026-08-20) |
| Nov. 22, 2016 | CHCT | P 10b5-1 | 10,731 | $22.35 | $239,838 | 351,675 Direct | +3.15% | Acquired | -34.4% (price as of 2026-08-20) |
| Nov. 21, 2016 | CHCT | P 10b5-1 | 10,486 | $22.07 | $231,426 | 340,944 Direct | +3.17% | Acquired | -33.6% (price as of 2026-08-20) |
| Nov. 18, 2016 | CHCT | P 10b5-1 | 10,061 | $21.92 | $220,537 | 330,458 Direct | +3.14% | Acquired | -33.1% (price as of 2026-08-20) |
| Nov. 17, 2016 | CHCT | P 10b5-1 | 9,906 | $21.78 | $215,753 | 320,397 Direct | +3.19% | Acquired | -32.7% (price as of 2026-08-20) |
| Oct. 7, 2016 | CHCT | P 10b5-1 | 11,332 | $22.58 | $255,877 | 310,491 Direct | +3.79% | Acquired | -35.1% (price as of 2026-08-20) |
| Oct. 6, 2016 | CHCT | P 10b5-1 | 11,218 | $21.92 | $245,899 | 299,159 Direct | +3.90% | Acquired | -33.1% (price as of 2026-08-20) |
| Oct. 5, 2016 | CHCT | P 10b5-1 | 11,120 | $21.44 | $238,413 | 287,941 Direct | +4.02% | Acquired | -31.6% (price as of 2026-08-20) |
| Sept. 21, 2016 | CHCT | P 10b5-1 | 13,401 | $21.97 | $294,420 | 276,821 Direct | +5.09% | Acquired | -33.3% (price as of 2026-08-20) |
| Sept. 20, 2016 | CHCT | P 10b5-1 | 13,088 | $21.66 | $283,486 | 263,420 Direct | +5.23% | Acquired | -32.3% (price as of 2026-08-20) |
| Sept. 19, 2016 | CHCT | P 10b5-1 | 12,170 | $21.66 | $263,602 | 250,332 Direct | +5.11% | Acquired | -32.3% (price as of 2026-08-20) |
| Sept. 16, 2016 | CHCT | P 10b5-1 | 9,906 | $21.16 | $209,611 | 238,162 Direct | +4.34% | Acquired | -30.7% (price as of 2026-08-20) |
| Sept. 15, 2016 | CHCT | P 10b5-1 | 9,616 | $21.44 | $206,167 | 228,256 Direct | +4.40% | Acquired | -31.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CHCT
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | — | — | $1,015,989 | — | — | — | $22,913,954 | $24,793,238 |
| 2022 | — | — | $2,820,373 | — | — | — | $12,425 | $4,540,328 |
| 2021 | — | — | $3,164,711 | — | — | — | $11,650 | $4,788,861 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.